[3H]Epibatidine binding to bovine adrenal medulla: evidence for α3β4* nicotinic receptors
Authors:
- Darrell L. BryantDBDarrell L. Bryant
- Susan B. McKaySMSusan B. McKay
- Daniel J. KaserDKDaniel J. Kaser
- Dennis B. McKayDMDennis B. McKay
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 318 (2) , 98-102
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Structure–activity studies with ring E analogues of methyllycaconitine on bovine adrenal α3β4* nicotinic receptorsNeuroscience Research, 2002
- Antagonism of nicotinic receptors of rat chromaffin cells by N,N,N-trimethyl-1-(4-trans -stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding studyBritish Journal of Pharmacology, 2000
- Neuronal Nicotinic Acetylcholine Receptors on Bovine Chromaffin Cells: Cloning, Expression, and Genomic Organization of Receptor SubunitsJournal of Neurochemistry, 1997
- Neuronal Nicotinic Receptor Expression in Sensory Neurons of the Rat Trigeminal Ganglion: Demonstration of α3β4, a Novel Subtype in the Mammalian Nervous SystemJournal of Neuroscience, 1996
- α‐Bungarotoxin‐sensitive Nicotinic Receptors on Bovine Chromaffin Cells: Molecular Cloning, Functional Expression and Alternative Splicing of the α7 SubunitEuropean Journal of Neuroscience, 1995
- Agonist pharmacology of the neuronal α7 nicotinic receptor expressed in Xenopus oocytesFEBS Letters, 1993
- Characterization of nicotinic acetylcholine receptors on cultured bovine adrenal chromaffin cells using modified l-[3H]nicotine binding assayNaunyn-Schmiedeberg's Archives of Pharmacology, 1992
- A desensitized form of neuronal acetylcholine receptor detected by 3H- nicotine binding on bovine adrenal chromaffin cells [published erratum appears in J Neurosci 1988 Dec;8(12):preceding 4415]Journal of Neuroscience, 1988
- Use of isolated chromaffin cells to study basic release mechanismsJournal of the Autonomic Nervous System, 1983
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973